Clinical trials of monoclonal antibodies to treat and prevent COVID-19 at Washington University.
Kathleen Berger and Dr. Rachel Presti, principal investigator for Eli Lilly monoclonal antibody therapy, discuss clinical trials of monoclonal antibodies as a possible tool to help treat and prevent COVID-19 infections.
| Other Authors: | , |
|---|---|
| Format: | Video |
| Language: | English |
| Language Notes: | Closed-captioned in English. |
| Published: |
[Place of publication not identified] :
Educate Today,
2020.
|
| Subjects: | |
| Online Access: | Connect to this streaming video |
| Summary: | Kathleen Berger and Dr. Rachel Presti, principal investigator for Eli Lilly monoclonal antibody therapy, discuss clinical trials of monoclonal antibodies as a possible tool to help treat and prevent COVID-19 infections. |
|---|---|
| Physical Description: | 1 online resource (1 video file (00:03:04)) : sound, colour |
| ISBN: | 9781529789959 1529789958 |